Clinical Trials
Testing what the body of research suggests: that a patient’s underlying biology, not a one-size-fits-all protocol, should guide their treatment.
Right Treatment. Right Patient.
Today, steroids are prescribed broadly for patients at risk of acute respiratory distress syndrome (ARDS), with little insight into which patients actually benefit and which don’t. Our clinical trials – conducted with leading academic research partners and supported in part by federal funding – are designed to answer that question directly, by tapping into individual patient biology to determine which patients will respond to which treatments, and training our models to recognize those patterns in future patients.
Going Further. Together.
Built with the Nation’s Leading Research Centers
Our trials run in partnership with Vanderbilt Coordinating Center and the STRIVE Network, a consortium of top academic research centers focused on respiratory disease. By integrating directly with hospital systems, our precision medicine platform helps sites quickly identify eligible patients and needed samples, making it easier for leading research centers to participate. The faster we learn, the faster we can turn what we learn into targeted therapies.

See People Differently
Successful Clinical Trials for Acute Illness
Clinical trials for acute conditions like sepsis, ARDS, and acute kidney injury have largely been unsuccessful. Until now. Prenosis has the biological map, combined with AI and machine learning tools, to select patients for individual, tailored trials. And with each new trial, our biobank expands, giving our precision medicine platform the data needed to help hospitals quickly identify eligible patients, manage samples, and participate in the next study.

Fulfilling the Vision of Healthcare Tailored to Biology
See how our clinical trials fit into a broader research strategy built on data, partnership, and rigorous validation.

Proprietary Biobank and Dataset
Every trial adds to NOSIS, the biobank powering Immunix and sharpening our understanding of acute illness.

Validated by Peer-Reviewed Evidence
Explore the peer-reviewed research behind our approach to precision medicine in acute care.




